Release Date: 19/11/13 15:51 Summary: Quarterly Cashflow Report Price Sensitive: No Download Document 105.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%